ArticleBMC pulmonary medicine2022

Cost-effectiveness of the anti-fibrotics for the treatment of idiopathic pulmonary fibrosis in the United States.

Timothy M Dempsey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.